###begin article-title 0
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 59 79 59 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobactor pylori </italic>
Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 51 71 51 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 72 81 72 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori</italic>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cagA</italic>
###xml 234 244 234 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 415 474 415 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) </italic>
###xml 51 70 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 72 81 <span type="species:ncbi:210">H. pylori</span>
###xml 234 243 <span type="species:ncbi:210">H. pylori</span>
Previous studies have revealed the significance of Helicobacter pylori (H. pylori) infection as a risk factor of gastric cancer. Cytotoxin-associated gene A (cagA) positivity has been demonstrated to determine the clinical outcome of H. pylori infection in the presence of SHP-2 (src homology 2 domain-containing protein tyrosine phosphatase-2). This study aimed to examine the formerly reported association of G/A PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) polymorphism (rs2301756) with gastric atrophy, as well as the association with gastric cancer in a Japanese population using a large sample size.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 272 282 272 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 337 347 337 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 272 281 <span type="species:ncbi:210">H. pylori</span>
###xml 337 346 <span type="species:ncbi:210">H. pylori</span>
Study subjects were 583 histologically diagnosed patients with gastric cancer (429 males and 154 females) and age- and sex-frequency-matched 1,636 non-cancer outpatients (1,203 males and 433 females), who visited Aichi Cancer Center Hospital between 2001-2005. Serum anti-H. pylori IgG antibody and pepsinogens were measured to evaluate H. pylori infection and gastric atrophy, respectively. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by a logistic model.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 6 16 6 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 129 131 129 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 144 147 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A</italic>
###xml 173 175 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A</italic>
###xml 221 223 221 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A</italic>
###xml 240 243 240 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A</italic>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/G </italic>
###xml 334 336 334 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 370 372 370 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 410 412 410 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 442 452 442 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 471 481 471 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 639 641 639 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 654 657 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A</italic>
###xml 658 661 658 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A</italic>
###xml 774 784 774 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 6 15 <span type="species:ncbi:210">H. pylori</span>
###xml 442 451 <span type="species:ncbi:210">H. pylori</span>
###xml 471 480 <span type="species:ncbi:210">H. pylori</span>
###xml 699 707 <span type="species:ncbi:9606">patients</span>
###xml 774 783 <span type="species:ncbi:210">H. pylori</span>
Among H. pylori seropositive non-cancer outpatients, the age- and sex-adjusted OR of gastric atrophy was 0.82 (95% CI 0.62-1.10, P = 0.194) for G/A, 0.84 (95% CI 0.39-1.81, P = 0.650) for A/A, and 0.83 (95% CI 0.62-1.09, P = 0.182) for G/A+A/A, relative to G/G genotype, and that of severe gastric atrophy was 0.70 (95% CI 0.47-1.04, P = 0.079), 0.56 (95% CI 0.17-1.91, P = 0.356), and 0.68 (95% CI 0.46-1.01, P = 0.057), respectively. Among H. pylori infected subjects (H. pylori seropositive subjects and seronegative subjects with gastric atrophy), the adjusted OR of severe gastric atrophy was further reduced; 0.62 (95% CI 0.42-0.90, P = 0.012) for G/A+A/A. The distribution of the genotype in patients with gastric cancer was not significantly different from that for H. pylori infected subjects without gastric atrophy.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A </italic>
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 353 363 353 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 411 418 411 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 353 362 <span type="species:ncbi:210">H. pylori</span>
Our study results revealed that those with the A/A genotype of PTPN11 rs2301756 polymorphism are at lower risk of severe gastric atrophy, but are not associated with a decreased risk of gastric cancer, which partially supported our previous finding that the polymorphism in the PTPN11 gene encoding SHP-2 was associated with the gastric atrophy risk in H. pylori infected Japanese. The biological roles of this PTPN11 polymorphism require further investigation.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori</italic>
###xml 188 198 188 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cagA</italic>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 688 698 688 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 709 710 709 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 711 712 711 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 812 813 812 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 863 873 863 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 877 881 877 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cagA</italic>
###xml 975 976 975 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1070 1074 1070 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cagA</italic>
###xml 1111 1115 1111 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cagA</italic>
###xml 1136 1140 1136 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cagA</italic>
###xml 1159 1160 1159 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 21 30 <span type="species:ncbi:210">H. pylori</span>
###xml 188 197 <span type="species:ncbi:210">H. pylori</span>
###xml 688 697 <span type="species:ncbi:210">H. pylori</span>
###xml 863 872 <span type="species:ncbi:210">H. pylori</span>
###xml 1045 1053 <span type="species:ncbi:9606">patients</span>
Helicobacter pylori (H. pylori) infection is a well-established risk factor of gastric cancer through the development of gastric atrophy and subsequent precancerous lesions. Particularly, H. pylori strains with the cytotoxin-associated gene A (cagA) are in a strong association with increased gastric adenocarcinoma risk [1]. Severe gastric atrophy and corpus-predominant gastritis along with intestinal metaplasia are well established as predominant predispositions to gastric cancer [2]. Host proinflammatory genetic factors in combination with bacterial virulence factors such as CagA have been reported to determine the severity of gastric damage and the eventual clinical outcome of H. pylori infection [3,4]. The risk of gastric cancer is multiplied several fold if the host harbors both of these factors [5,6]. In East Asian populations, great majority of H. pylori are cagA-positive strains. CagA is divided into two major subtypes, East Asian type and Western type [7]. The grade of gastric atrophy and gastric cancer risk is higher in patients with East Asian cagA-positive strains than in those with cagA-negative or Western cagA-positive strains [8].
###end p 11
###begin p 12
###xml 43 53 43 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cagA</italic>
###xml 374 384 374 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 742 744 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 43 52 <span type="species:ncbi:210">H. pylori</span>
###xml 374 383 <span type="species:ncbi:210">H. pylori</span>
CagA protein is translocated from attached H. pylori into host gastric epithelial cells via a bacterial type IV secretion apparatus, and undergoes tyrosine phosphorylation in the host cells [9]. It induces the scattering phenotypes in gastric epithelial cells, called the "hummingbird phenotype," which is thought to play a crucial role in the pathogenesis of cagA-positive H. pylori infection, eventually leading to gastric carcinoma. In this CagA-dependent morphological transformation of gastric epithelial cells, the existence of SHP-2 (src homology 2 domain-containing protein tyrosine phosphatase-2) is essential [10]. SHP-2 plays a key role in intracellular signaling downstream of a number of growth factors, hormones, and cytokines [11,12]. The translocated CagA forms a physical complex with SHP-2 thereby stimulating its phosphatase activity [10]. Subsequent Erk (extracellular signal-regulated kinase) activity also contributes to the CagA-induced "hummingbird phenotype" [13]. Thus, CagA/SHP-2 complex formation may induce abnormal proliferation, movement of gastric epithelial cells and cellular changes that might conclusively lead to gastric atrophy and gastric carcinoma.
###end p 12
###begin p 13
###xml 117 176 117 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) </italic>
###xml 397 404 397 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 542 545 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D' </italic>
###xml 553 554 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 554 556 554 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 597 600 597 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D' </italic>
###xml 608 609 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 609 611 609 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 749 752 749 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D' </italic>
###xml 760 761 760 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 761 763 761 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 869 880 869 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 G/A </italic>
###xml 938 949 938 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 G/A </italic>
###xml 980 982 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1004 1008 1004 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A </italic>
Since SHP-2 closely interacts with the CagA protein, it is natural to speculate that functional polymorphisms in the PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) gene encoding SHP-2 may ultimately influence the degree of gastric atrophy and transformation to gastric cancer in infected subjects. There are 9 single nucleotide polymorphisms (SNPs) at minor allele frequency > 0.05 in PTPN11 gene in Japanese on HapMap, all of which are located in non-coding regions, and most of them are in absolute linkage disequilibrium (LD) (D' = 1 and r2 = 1) or complete linkage disequilibrium (D' = 1 and r2 < 1) to each other. Five of the 9 SNPs are shown to be in complete LD and 3 of them are shown to be in absolute LD or nearly absolute LD (D' = 1 and r2 > 0.9) in Caucasians as shown in Figure 1, based on HapMap homepage . Our recent report revealed that one PTPN11 G/A SNP at intron 3 (rs2301756) was in complete LD to another PTPN11 G/A SNP at intron 10 (rs12229892) [14]. In this study, the G/A SNP at intron 3 (rs2301756), one of the 3 SNPs in absolute LD was selected as a representative of these linked SNPs.
###end p 13
###begin p 14
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 0 229 0 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Linkage disequilibrium (LD) between the 9 single nucleotide polymorphisms (SNPs) with a minor allele frequency &gt; 0.05 in the <italic>PTPN11 </italic>gene region among Caucasians (CEU: Utah residents with ancestry from northern and western Europe)</bold>
###xml 268 269 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 269 271 269 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
Linkage disequilibrium (LD) between the 9 single nucleotide polymorphisms (SNPs) with a minor allele frequency > 0.05 in the PTPN11 gene region among Caucasians (CEU: Utah residents with ancestry from northern and western Europe). LD maps are shown by two parameters, r2 and D' for Caucasians (CEU: Utah residents with ancestry from northern and western Europe). SNP numbers in the LD maps correspond to the rs numbers described in the upper right of the maps.
###end p 14
###begin p 15
###xml 3 13 3 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 85 95 85 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 301 313 301 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">interleukin </italic>
###xml 314 316 314 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL</italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-1B </italic>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 362 396 362 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tumor necrosis factor (TNF)-&#945; </italic>
###xml 430 432 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 474 481 470 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(NQO1) </italic>
###xml 501 503 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 510 520 506 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 553 557 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A </italic>
###xml 585 610 581 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Grb2-associated binder 1 </italic>
###xml 611 615 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gab1</italic>
###xml 618 620 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 623 635 619 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">interleukin </italic>
###xml 636 638 632 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL</italic>
###xml 654 660 650 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-13 </italic>
###xml 669 671 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 780 795 776 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mucin 1 (MUC1) </italic>
###xml 829 839 825 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 850 852 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 853 855 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1075 1077 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 3 12 <span type="species:ncbi:210">H. pylori</span>
###xml 85 94 <span type="species:ncbi:210">H. pylori</span>
###xml 510 519 <span type="species:ncbi:210">H. pylori</span>
###xml 829 838 <span type="species:ncbi:210">H. pylori</span>
In H. pylori related gastric cancer, the process leading to disease has three steps; H. pylori infection, gastric atrophy development and carcinogenesis. At each step, genetic traits and their interactions with lifestyle may influence the process [15]. For genetic traits, significant associations of interleukin (IL) -1B C-31T and C-511T polymorphisms [16,17], tumor necrosis factor (TNF)-alpha C-857T and T-1031C polymorphisms [18], and a NAD(P)H dehydrogenase, quinone 1 (NQO1) C609T polymorphism [19] with H. pylori infection, and associations of a G/A polymorphism at intron 2 of Grb2-associated binder 1 (Gab1) [20], interleukin (IL) 2 T-330G, and IL-13 C-1111T [21] with gastric atrophy have been reported to date. Variable number of tandem repeats (VNTR) polymorphisms of mucin 1 (MUC1) have also been shown to influence H. pylori infection [22,23]. Although there are several studies to demonstrate the polymorphisms significantly associated with the risk of gastric cancer, only a few studies evaluated the risk for the step from gastric atrophy to gastric cancer [15].
###end p 15
###begin p 16
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AA </italic>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 179 186 179 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 394 401 394 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
In our previous studies among Japanese and Japanese Brazilians, the AA genotype in intron 3 was shown to reduce the risk of gastric atrophy development [24,25]. Recently, another PTPN11 SNP (rs11066322 at intron 10 in complete linkage disequilibrium to rs2301756) was found to be significantly associated with serum apoB levels in a British population [26], supporting the hypothesis that this PTPN11 polymorphism is functional. This study aimed to confirm the formerly reported association between the PTPN11 polymorphism (rs2301756) and gastric atrophy measured with serum pepsinogens in a large number of Japanese subjects, as well as to examine the association with gastric cancer risk.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Subjects
###end title 18
###begin p 19
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 14 26 <span type="species:ncbi:9606">participants</span>
###xml 268 280 <span type="species:ncbi:9606">participants</span>
Subjects were participants of HERPACC (Hospital-based Epidemiologic Research Program at Aichi Cancer Center) study, in which first-visit outpatients were consecutively invited to provide lifestyle data and blood sample after obtaining informed consent [27]. Among the participants who visited Aichi Cancer Center Hospital from 2001 - 2005, 583 cases diagnosed as gastric cancer and age- and sex-frequency-matched 1,638 cancer free outpatients were sampled as a control group, among whom two outpatients were excluded because they could not be genotyped, leaving 583 cases and 1,636 controls eligible for the analyses. Informed consent was obtained from all the subjects and the study protocol was approved by the Ethics Committees of Aichi Cancer Center and Nagoya University Graduate School of Medicine.
###end p 19
###begin title 20
Samples and diagnostic criteria
###end title 20
###begin p 21
###xml 80 90 74 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 170 180 164 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 80 89 <span type="species:ncbi:210">H. pylori</span>
###xml 170 179 <span type="species:ncbi:210">H. pylori</span>
Their serum samples were immediately stored at -20degreesC until analysis. Anti-H. pylori IgG antibody was measured with an enzyme immunoassay (EIA) kit "E plate 'Eiken' H. pylori Antibody" (Eiken Kagaku, Tokyo, Japan). According to the instructions provided with this kit, 10.0 units or higher was regarded as seropositive. Serum pepsinogens (PG) were measured by chemiluminescence enzyme immunoassay (CLEIA). Gastric mucosal atrophy was grouped into "none" (PG I > 70 ng/ml or PG I/PG II > 3), "mild" (PG I </= 70 ng/ml and PG I/PG II </= 3, excluding "severe" cases), or "severe" (PG I </= 30 ng/ml and PG I/PG II </= 2). Since serum samples of gastric cancer cases were planned to be used for a study with higher priority, the antibody and PGs of the cases were not measured.
###end p 21
###begin title 22
Genotyping
###end title 22
###begin p 23
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 722 726 692 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/G </italic>
###xml 758 762 728 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A </italic>
###xml 783 787 753 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A </italic>
###xml 825 827 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
DNA was extracted from buffy coat using the Qiagen DNeasy mini kit (Qiagen, Hilden, Germany). The PTPN11 G/A polymorphism (rs2301756) was genotyped with a polymerase chain reaction with confronting two-pair primers (PCR-CTPP) [28]. The primers were F1: GGA TTA CAG GCA TAA GCC AC, R1: GAC CAC TAA ACT TCT TAA ATG AGC, F2: CAT TTG TCT CTA AAG GAC TGT GGA, and R2: CTC TGG CTC TCT CGT ACA AGA. Amplification conditions were 10 min of initial denaturation at 95degreesC, followed by 30 cycles of 1 min at 95degreesC, 1 min at 64degreesC, and 1 min at 72degreesC, then a 5-min final extension at 72degreesC. The amplified DNA was visualized on a 2% agarose gel with ethidium bromide staining. The amplified DNA was 201 bp for G/G genotype, 201 bp and 339 bp for G/A genotype, 339 bp for A/A genotype, and 490 bp for common band [24].
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 327 337 327 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 381 391 381 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 501 511 501 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 538 548 538 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 657 659 655 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 327 336 <span type="species:ncbi:210">H. pylori</span>
###xml 381 390 <span type="species:ncbi:210">H. pylori</span>
###xml 501 510 <span type="species:ncbi:210">H. pylori</span>
###xml 538 547 <span type="species:ncbi:210">H. pylori</span>
The differences in proportions were examined with a Fisher's exact test. The 95% confidence intervals (CIs) for percentages were calculated based on binomial distributions. Logistic regression analysis was performed for estimating odds ratios (ORs) and 95% CIs. Age was adjusted as a continuous variable in the logistic model. H. pylori infected subjects was defined as those with H. pylori seropositivity or with gastric atrophy, because in the great majority of cases gastric atrophy develops after H. pylori infections. The trends for H. pylori infection, gastric atrophy or gastric cancer development by sex or age categories were compared using the chi2 test for trend. The calculations were done using the STATA version 7 (Stata Corp, College Station, TX).
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
Characteristics of the subjects and allele frequency of the PTPN11 polymorphism
###end title 27
###begin p 28
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 304 313 298 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori</italic>
###xml 404 411 398 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 483 485 475 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 494 496 486 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 530 540 522 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 667 677 659 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 702 703 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 756 758 748 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 839 841 831 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 304 313 <span type="species:ncbi:210">H. pylori</span>
###xml 530 539 <span type="species:ncbi:210">H. pylori</span>
###xml 667 676 <span type="species:ncbi:210">H. pylori</span>
The characteristics of the subjects are summarized in Table 1. The mean age +/- standard deviation was 58.7 +/- 10.6 y (range: 25-84 y) for controls and 58.8 +/- 10.5 y (range: 27-80 y) for cases. Females were 26.5% in controls and 26.4% in cases. About three quarters of the controls were infected with H. pylori, while about one third of the controls had gastric atrophy. The genotype frequency of the PTPN11 polymorphism among the controls was in Hardy-Weinberg's equilibrium (chi2 = 0.047, P = 0.828). We tested the trend for H. pylori infection, gastric atrophy or gastric cancer development by sex or age categories, which revealed significant trend for higher H. pylori infection rate in males (P-value for trend < 0.001) and higher age categories (P < 0.001), and for higher prevalence of gastric atrophy in higher age categories (P < 0.001).
###end p 28
###begin p 29
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
Characteristics of the subjects and the PTPN11 rs2301756 polymorphism.
###end p 29
###begin p 30
GA(-) and GA(+) indicate without atrophy and with atrophy, respectively.
###end p 30
###begin title 31
###xml 21 31 21 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 21 30 <span type="species:ncbi:210">H. pylori</span>
PTPN11 polymorphism, H. pylori seropositivity, gastric atrophy and gastric cancer
###end title 31
###begin p 32
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A </italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/G </italic>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
There was no significant association between the PTPN11 polymorphism and the seropositivity, although the OR of A/A genotype was 1.19 relative to G/G genotype (Table 2).
###end p 32
###begin p 33
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 90 100 90 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 90 99 <span type="species:ncbi:210">H. pylori</span>
Odds ratios (ORs) and 95% confidence intervals (CIs) of PTPN11 rs2301756 polymorphism for H. pylori seropositivity.
###end p 33
###begin p 34
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aOR for each genotype was calculated by age and sex adjusted logistic regression model, and a crude OR was calculated for each allele.
###end p 34
###begin p 35
###xml 15 25 15 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 250 252 250 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 15 24 <span type="species:ncbi:210">H. pylori</span>
There were 937 H. pylori seropositive subjects, among whom 495 (52.8%) subjects had atrophy. On the one hand, there were 45 (6.4%) subjects with atrophy among 699 seronegative subjects. The difference in the prevalence was statistically significant (P < 0.001).
###end p 35
###begin p 36
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A </italic>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A </italic>
###xml 400 402 400 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 153 165 <span type="species:ncbi:9606">participants</span>
Table 3 shows the genotype distribution according to seropositivity and atrophy. There were no subjects with A/A genotype among the seronegative atrophy participants. Accordingly, the adjusted OR of gastric atrophy among the seronegative subjects was not calculable for the A/A genotype; the genotype distribution was not significantly associated with gastric atrophy by a 3 x 3 Fisher's exact test (P = 0.196).
###end p 36
###begin p 37
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 52 62 52 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 52 61 <span type="species:ncbi:210">H. pylori</span>
PTPN11 rs2301756 genotype distribution according to H. pylori seropositivity and the grade of gastric atrophy.
###end p 37
###begin p 38
GA(-), GA(+) and GA(++) indicate no atrophy, mild atrophy and severe atrophy, respectively.
###end p 38
###begin p 39
###xml 54 64 54 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 114 116 114 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A</italic>
###xml 158 160 158 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A</italic>
###xml 206 208 206 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A</italic>
###xml 225 228 225 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A</italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/G </italic>
###xml 319 329 319 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 379 381 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 394 397 394 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A</italic>
###xml 423 425 423 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 438 441 438 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A</italic>
###xml 471 473 471 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 486 489 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A</italic>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A </italic>
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 580 590 580 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 676 686 676 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 770 780 770 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 834 836 834 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 849 852 849 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A</italic>
###xml 853 857 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A </italic>
###xml 864 865 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 54 63 <span type="species:ncbi:210">H. pylori</span>
###xml 319 328 <span type="species:ncbi:210">H. pylori</span>
###xml 580 589 <span type="species:ncbi:210">H. pylori</span>
###xml 676 685 <span type="species:ncbi:210">H. pylori</span>
###xml 770 779 <span type="species:ncbi:210">H. pylori</span>
The age- and sex-adjusted OR of gastric atrophy among H. pylori seropositive subjects was 0.82 (95% CI 0.62-1.10, P = 0.194) for G/A, 0.84 (95% CI 0.39-1.81, P = 0.650) for A/A, and 0.83 (95% CI 0.62-1.09, P = 0.182) for G/A+A/A, compared with G/G genotype. The age- and sex-adjusted OR of severe gastric atrophy among H. pylori seropositive subjects was 0.70 (95% CI 0.47-1.04, P = 0.079) for G/A, 0.56 (95% CI 0.17-1.91, P = 0.356) for A/A, and 0.68 (95% CI 0.46-1.01, P = 0.057) for G/A+A/A when those without severe gastric atrophy were defined as a reference (Table 4). When H. pylori seropositive subjects and seronegative subjects with gastric atrophy were regarded as H. pylori infected subjects, the age- and sex-adjusted OR of severe gastric atrophy among the H. pylori infected was further reduced; 0.62 (95% CI 0.42-0.90, P = 0.012) for G/A+A/A (Table 4).
###end p 39
###begin p 40
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 135 145 135 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 175 184 175 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H.pylori </italic>
###xml 135 144 <span type="species:ncbi:210">H. pylori</span>
###xml 175 183 <span type="species:ncbi:210">H.pylori</span>
Genotype frequencies for PTPN11 rs2301756 polymorphism, odds ratios (ORs) and 95% confidence intervals (CIs) of gastric atrophy in the H. pylori seropositive subjects (a) and H.pylori infected subjects (b)
###end p 40
###begin p 41
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aOR for each genotype was calculated by age and sex adjusted logistic regression model, and a crude OR was calculated for each allele.
###end p 41
###begin p 42
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1 3 1 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Italics</italic>
bP values less than 0.05 are shown in Italics.
###end p 42
###begin p 43
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 105 115 105 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 207 209 205 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A </italic>
###xml 362 364 360 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A </italic>
###xml 387 391 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/G </italic>
###xml 105 114 <span type="species:ncbi:210">H. pylori</span>
Figure 2 depicts the distributions of pepsinogen I/II ratio according to PTPN11 rs2301756 genotype among H. pylori infected subjects with PG I </= 70 ng/ml. In accordance with the finding that subjects with A allele were at significantly reduced risk of severe gastric atrophy, the frequency of subjects with PG I/II ratio less than 2 was lower in subjects with A allele than those with G/G genotype.
###end p 43
###begin p 44
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 89 99 89 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 0 150 0 148 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Distributions of pepsinogen (PG) I/II ratio according to <italic>PTPN11 </italic>rs2301756 genotype among <italic>H. pylori </italic>infected subjects with a PG I level of &#8804; 70 ng/ml</bold>
###xml 89 98 <span type="species:ncbi:210">H. pylori</span>
Distributions of pepsinogen (PG) I/II ratio according to PTPN11 rs2301756 genotype among H. pylori infected subjects with a PG I level of </= 70 ng/ml.
###end p 44
###begin p 45
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 99 109 99 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 186 196 186 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 314 316 314 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 329 332 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A</italic>
###xml 358 360 358 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 373 376 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A</italic>
###xml 406 408 406 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 421 424 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A</italic>
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A</italic>
###xml 442 446 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/G </italic>
###xml 508 509 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 99 108 <span type="species:ncbi:210">H. pylori</span>
###xml 186 195 <span type="species:ncbi:210">H. pylori</span>
To investigate how this polymorphism of PTPN11 contributes to the gastric carcinogenesis among the H. pylori infected subjects, we also calculated the OR of gastric cancer compared with H. pylori infected subjects without gastric atrophy. The age- and sex-adjusted OR of gastric cancer was 0.97 (95% CI 0.74-1.28, P = 0.839) for G/A, 0.71 (95% CI 0.33-1.53, P = 0.381) for A/A, and 0.95 (95% CI 0.73-1.23, P = 0.689) for G/A+A/A, relative to G/G genotype, none of which were statistically significant (Table 5).
###end p 45
###begin p 46
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 156 166 156 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 156 165 <span type="species:ncbi:210">H. pylori</span>
Genotype frequencies for PTPN11 rs2301756 polymorphism, age-sex adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of gastric cancer relative to H. pylori infected subjects without gastric atrophy (HP-infected without atrophy).
###end p 46
###begin p 47
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aOR for each genotype was calculated by age and sex adjusted logistic regression model, and a crude OR was calculated for each allele.
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 42 44 42 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A </italic>
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cagA</italic>
###xml 253 263 253 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 300 304 300 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A/A </italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/G </italic>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 253 262 <span type="species:ncbi:210">H. pylori</span>
This study revealed that those who harbor A allele of the PTPN11 rs2301756 polymorphism at intron 3 had a significantly lower risk of severe gastric atrophy. This is in accordance with our hypothesis that gastric atrophy development after cagA-positive H. pylori infection was rarer among those with A/A genotype than among those with G/G genotype [24,25], although the significant association was observed only for severe gastric atrophy in this study. Since the biological processes in infection, atrophy development, and carcinogenesis are different [15], the association of this polymorphism with only atrophic development seemed biologically plausible.
###end p 49
###begin p 50
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 583 587 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G/A </italic>
###xml 619 626 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 872 879 872 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 1059 1066 1059 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 1087 1088 1087 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1206 1213 1206 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 1275 1276 1275 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1299 1306 1299 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 1351 1358 1351 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
While there was limited information on the potential function of PTPN11 polymorphisms, biological characteristics of SHP-2 have become increasingly understood. SHP-2 is one of the two existing mammalian non-transmembrane (intracellular) protein tyrosine phosphatases (PTPs) that contain src homology 2 (SH2) domains. Binding of tyrosine phosphorylated CagA to the SH2 domains is supposed to induce conformational change in SHP-2 that weakens the inhibitory interaction between PTP and N-terminal SH2 domains, eventually leading to the activation of SHP-2 phosphatase [10,29,30]. The G/A polymorphism in the intron 3 of PTPN11 is located 223 base pairs upstream from exon 4, which encodes the initial part of C-terminal SH2 domain. Although the biological role of the present polymorphism is not yet clearified, the polymorphism may have some influence on the formation of PTPN11 mRNA splicing variants, of which 8 forms have been reported to date (SpliceMinor homepage developed by The Genomics & Bioinformatics Group (GBG) of NCI: ). The LD data between the PTPN11 SNPs shown in Figure 1 is that for Caucasians, and no precise information about LD in Japanese is available at present. There are also some PTPN11 SNPs whose LD status is left unknown (SNP8 and SNP9 in Figure 1). The function of the PTPN11 polymorphism at exon 3 (rs2301756) and other PTPN11 SNPs on the interaction between SHP-2 and CagA in Japanese and other ethnicities requires further investigation.
###end p 50
###begin p 51
###xml 13 15 13 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G </italic>
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
Although the G allele of PTPN11 may be a part of the genetic traits to develop gastric atrophy via signal transduction from CagA, there seems to be other genetic traits involved in this process. CagA binds several molecules; Grb2, which transduces the signal to Ras-MAPK pathway causing cell proliferation, c-Met hepatocyte growth factor (HGF) receptor, which have a role of cell proliferation and motility, ZO-1, a tight-junction protein, and Par1/Mark kinase, which has an essential role in epithelial cell polarity [31-35]. Although no studies have been conducted, functional polymorphisms of these molecules might be also candidates of genetic traits of gastric atrophy.
###end p 51
###begin p 52
###xml 4 6 4 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A </italic>
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 238 240 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A </italic>
The A allele was the dominant allele of PTPN11 polymorphism at intron 3 among Caucasians (0.875 of 120 chromosomes), but not among Japanese (0.178 of 902 chromosomes) and Chinese (0.083 of 48 choromosomes) [26]. This study found that the A allele frequency was 0.170 among our Japanese control subjects, similar to the reported allele frequency in Japanese.
###end p 52
###begin p 53
###xml 56 66 56 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 203 213 203 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cag </italic>
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cag </italic>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cagA</italic>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 480 490 480 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 898 900 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1181 1183 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1184 1186 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1229 1239 1221 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 1345 1355 1337 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 1392 1394 1384 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1395 1397 1387 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1539 1549 1531 1541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 1630 1632 1622 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1787 1794 1779 1786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 2064 2074 2056 2066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 2128 2135 2120 2127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 2149 2151 2141 2143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2152 2154 2144 2146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 56 65 <span type="species:ncbi:210">H. pylori</span>
###xml 203 212 <span type="species:ncbi:210">H. pylori</span>
###xml 480 489 <span type="species:ncbi:210">H. pylori</span>
###xml 1229 1238 <span type="species:ncbi:210">H. pylori</span>
###xml 1345 1354 <span type="species:ncbi:210">H. pylori</span>
###xml 1539 1548 <span type="species:ncbi:210">H. pylori</span>
###xml 2064 2073 <span type="species:ncbi:210">H. pylori</span>
The present study has several limitations. Although the H. pylori status of the control subjects was examined with a serology test, we did not check the CagA status. As reported in Japan, nearly 100% of H. pylori strains possess a functional cag pathogenicity island (cag PAI), which encodes and produces the CagA protein [36]. A previous study also certified that almost all strains isolated from our Japanese subjects were East Asian cagA-positive strains [37], indicating that H. pylori strains in our study subjects also possesses CagA. Another limitation is related to the diagnosis of gastric atrophy. This was done entirely on the basis of serum pepsinogen levels and not through histological assessment, because most of the control subjects did not undergo gastrointestinal endoscopy with biopsy. However, the pepsinogen method is well established as a surrogate marker of gastric atrophy [38-40]. The validated criterion for gastric atrophy is PG I </= 70 ng/ml and PG I/II ratio of </= 3.0, and that for severe gastric atrophy is PG I </= 30 ng/ml and PG I/II ratio of </= 2.0, both of which are supposed to be reliable because they are widely used in practice in Japan [41,42]. Concerning the gastric cancer cases the H. pylori seropositivity and pepsinogen levels were not examined, but most of the gastric cancer cases seemed to be H. pylori positive cases with gastric atrophy [43,44]. Considering that intestinal type of gastric cancer, the predominant type of gastric cancer in Japan, arises from gastric atrophy caused by H. pylori infection, and diffuse type gastric cancer occurs regardless of gastric atrophy [45], it would seem intriguing to perform the subgroup analysis according to these two histological types. This analysis might unveil the association of this PTPN11 polymorphism with the steps of gastric carcinogenesis more clearly. However, we could not perform this analysis because of the unavailability of the histological data. In addition, there might be several factors, including genetic, that prime the individual stomach for H. pylori colonization, which might modulate the effect of this PTPN11 polymorphism [22,23]. Further investigations with these factors taken into consideration are also expected.
###end p 53
###begin title 54
Conclusion
###end title 54
###begin p 55
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 117 127 117 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 285 292 285 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 434 443 434 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori</italic>
###xml 117 126 <span type="species:ncbi:210">H. pylori</span>
###xml 434 443 <span type="species:ncbi:210">H. pylori</span>
This study revealed that rs2301756 in the PTPN11 gene encoding SHP-2 increased the risk of severe gastric atrophy in H. pylori infected subjects in Japan. Although the significant association was limited only to severe gastric atrophy, this study partially supported the roles of this PTPN11 polymorphism in the gastric atrophy development. Elucidation of the function of this polymorphism will help us understand the pathogenesis of H. pylori-induced gastric cancer, which will lead to more effective means for the personalized prevention of gastric atrophy and subsequent gastric cancer in the near future.
###end p 55
###begin title 56
Competing interests
###end title 56
###begin p 57
The authors declare that they have no competing interests.
###end p 57
###begin title 58
Authors' contributions
###end title 58
###begin p 59
###xml 113 125 <span type="species:ncbi:9606">participants</span>
AH: Conducted data analysis and drafted the manuscript. KM and YG: Contributed greatly to the recruitment of the participants and data collection, and advised in preparing the manuscript. MN and KW: Contributed to data analysis, and advised in preparing the manuscript. KT and NH: Supervised study design, data collection and analysis, and advised in preparing the manuscript. All authors have given final approval of the version to be submitted.
###end p 59
###begin title 60
Pre-publication history
###end title 60
###begin p 61
The pre-publication history for this paper can be accessed here:
###end p 61
###begin p 62

###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
The authors wish to thank all the staff involved in this study and are grateful to Ms. Yoko Mitsuda for her technical assistance. This study was supported in part by a Grant-in-Aid for Scientific Research on Special Priority Areas of Cancer from the Japanese Ministry of Education, Culture, Sports, Science and Technology.
###end p 64
###begin article-title 65
###xml 15 34 <span type="species:ncbi:210">Helicobacter pylori</span>
Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
###end article-title 65
###begin article-title 66
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori infection and the development of gastric cancer
###end article-title 66
###begin article-title 67
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
###end article-title 67
###begin article-title 68
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma
###end article-title 68
###begin article-title 69
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma
###end article-title 69
###begin article-title 70
###xml 22 41 <span type="species:ncbi:210">Helicobacter pylori</span>
Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa
###end article-title 70
###begin article-title 71
###xml 50 69 50 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori</italic>
###xml 50 69 <span type="species:ncbi:210">Helicobacter pylori</span>
Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH
###end article-title 71
###begin article-title 72
###xml 107 127 107 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 107 126 <span type="species:ncbi:210">Helicobacter pylori</span>
Association between diversity in the src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer
###end article-title 72
###begin article-title 73
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells
###end article-title 73
###begin article-title 74
###xml 57 76 <span type="species:ncbi:210">Helicobacter pylori</span>
SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein
###end article-title 74
###begin article-title 75
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
###end article-title 75
###begin article-title 76
SHP-2 and myeloid malignancies
###end article-title 76
###begin article-title 77
###xml 103 122 <span type="species:ncbi:210">Helicobacter pylori</span>
Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori
###end article-title 77
###begin article-title 78
Associations between a PTPN11 polymorphism and gastric atrophy - opposite in Uzbekistan to that in Japan
###end article-title 78
###begin article-title 79
###xml 47 66 <span type="species:ncbi:210">Helicobacter pylori</span>
Genetic factors involved in the development of Helicobacter pylori-related gastric cancer
###end article-title 79
###begin article-title 80
###xml 52 71 <span type="species:ncbi:210">Helicobacter pylori</span>
Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection
###end article-title 80
###begin article-title 81
Association of the interleukin-1beta genetic polymorphism and gastric cancer risk in Japanese
###end article-title 81
###begin article-title 82
###xml 12 31 <span type="species:ncbi:210">Helicobacter pylori</span>
The highest Helicobacter pylori seropositive rate among those with TNF-A-857TT and -1031TT: genotypes
###end article-title 82
###begin article-title 83
###xml 20 39 <span type="species:ncbi:210">Helicobacter pylori</span>
Association between Helicobacter pylori seropositivity and NAD(P)H quinone oxidoreductase 1 (NQO1) C609T polymorphism observed for outpatients and health checkup examinees
###end article-title 83
###begin article-title 84
Grb2-associated binder 1 polymorphism was associated with the risk of Helicobactor pylori infection and gastric atrophy
###end article-title 84
###begin article-title 85
###xml 88 107 <span type="species:ncbi:210">Helicobacter pylori</span>
Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection
###end article-title 85
###begin article-title 86
Short mucin 1 alleles are associated with low virulent H pylori strains infection
###end article-title 86
###begin article-title 87
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 61 80 <span type="species:ncbi:210">Helicobacter pylori</span>
Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection
###end article-title 87
###begin article-title 88
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
###xml 86 106 86 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 86 105 <span type="species:ncbi:210">Helicobacter pylori</span>
Association between serum pepsinogens and polymorphism of PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese
###end article-title 88
###begin article-title 89
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN11 </italic>
Significant association between PTPN11 polymorphism and gastric atrophy among Japanese Brazilians
###end article-title 89
###begin article-title 90
###xml 107 112 <span type="species:ncbi:9606">women</span>
SHP-2 and PI3-kinase genes PTPN11 and PIK3R1 may influence serum apoB and LDL cholesterol levels in normal women
###end article-title 90
###begin article-title 91
###xml 47 55 <span type="species:ncbi:9606">patients</span>
A Model of Practical Cancer Prevention for Out-patients Visiting a Hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC)
###end article-title 91
###begin article-title 92
Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping
###end article-title 92
###begin article-title 93
###xml 27 47 27 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 27 46 <span type="species:ncbi:210">Helicobacter pylori</span>
Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites
###end article-title 93
###begin article-title 94
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori CagA - a bacterial intruder conspiring gastric carcinogenesis
###end article-title 94
###begin article-title 95
###xml 26 46 26 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 26 45 <span type="species:ncbi:210">Helicobacter pylori</span>
Grb2 is a key mediator of Helicobacter pylori CagA protein activities
###end article-title 95
###begin article-title 96
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response
###end article-title 96
###begin article-title 97
###xml 15 35 15 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 15 34 <span type="species:ncbi:210">Helicobacter pylori</span>
Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase
###end article-title 97
###begin article-title 98
###xml 58 77 <span type="species:ncbi:210">Helicobacter pylori</span>
Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA
###end article-title 98
###begin article-title 99
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity
###end article-title 99
###begin article-title 100
###xml 67 86 <span type="species:ncbi:210">Helicobacter pylori</span>
Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan
###end article-title 100
###begin article-title 101
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori </italic>
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori CagA protein variation associated with gastric cancer in Asia
###end article-title 101
###begin article-title 102
Serum pepsinogens as a screening test of extensive chronic gastritis
###end article-title 102
###begin article-title 103
###xml 21 29 <span type="species:ncbi:9606">patients</span>
Serum pepsinogens in patients with gastric diseases or after gastric surgery
###end article-title 103
###begin article-title 104
Evaluation of blood tests to predict normal gastric mucosa
###end article-title 104
###begin article-title 105
Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males
###end article-title 105
###begin article-title 106
Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis
###end article-title 106
###begin article-title 107
###xml 0 19 <span type="species:ncbi:210">Helicobacter pylori</span>
Helicobacter pylori: present status and future prospects in Japan
###end article-title 107
###begin article-title 108
###xml 10 29 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 126 129 <span type="species:ncbi:9606">men</span>
###xml 134 139 <span type="species:ncbi:9606">women</span>
Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study
###end article-title 108
###begin article-title 109
###xml 26 45 <span type="species:ncbi:210">Helicobacter pylori</span>
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum
###end article-title 109

